Y. Chen

2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Papers on Lattice

Total citations

Topics

h-index

Publication activitypapers/week, last 8 weeks

Frequent co-authors

R. Nanda (1)Y. Abdou (1)N. Jahan (1)E. Mayer (1)M. Melisko (1)

Papers (1)

Feb 17, 2026

3w ago·also Corcept Therapeutics, Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Pfizer/Astellas +4

Abstract PS5-09-04: Tbcrc 058: a randomized phase 2 study of enzalutamide, enzalutamide with mifepristone, and treatment of physician’s choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (nct06099769)

This study will determine if enzalutamide, with or without mifepristone, improves progression-free survival compared to standard chemotherapy in patients with AR+ metastatic triple-negative or estrogen receptor-low breast cancer.

R. Nanda, Y. Chen, Y. Abdou +13

Search

Y. Chen

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (1)